Perspective Therapeutics (CATX) Inventory (2011 - 2023)

Perspective Therapeutics (CATX) has 13 years of Inventory data on file, last reported at $1.0 million in Q3 2023.

• For the quarter ending Q3 2023, Inventory fell 34.77% year-over-year to $1.0 million; the trailing twelve-month figure through Sep 2023 stood at $1.0 million (down 34.77% YoY), and the FY2022 full-year result was $1.4 million, changed N/A from the prior year.
• Inventory fell to $1.0 million in Q3 2023, from $1.1 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $1.6 million in Q3 2022 to a low of $501000.0 in Q3 2019.
• A 5-year average of $921842.1 and a median of $980000.0 in 2021 frame the typical range for Inventory.
• Across the five-year window, Inventory jumped 65.37% in 2021 and plunged 34.77% in 2023, its largest moves.
• Tracing CATX's Inventory over 5 years: stood at $545000.0 in 2019, then advanced by 22.02% to $665000.0 in 2020, then jumped by 60.6% to $1.1 million in 2021, then soared by 31.93% to $1.4 million in 2022, then dropped by 28.11% to $1.0 million in 2023.
• Business Quant data shows CATX's Inventory at $1.0 million in Q3 2023, $1.1 million in Q2 2023, and $1.4 million in Q1 2023.